Cargando…
Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London
OBJECTIVES: We examined the 4 year trend in antimicrobial susceptibilities and prescribing across levels of care at two London teaching hospitals and their multisite renal unit, and for the surrounding community. METHODS: Laboratory and pharmacy information management systems were interrogated, with...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228780/ https://www.ncbi.nlm.nih.gov/pubmed/25118270 http://dx.doi.org/10.1093/jac/dku307 |
_version_ | 1782344043177443328 |
---|---|
author | Moore, Luke S. P. Freeman, Rachel Gilchrist, Mark J. Gharbi, Myriam Brannigan, Eimear T. Donaldson, Hugo Livermore, David M. Holmes, Alison H. |
author_facet | Moore, Luke S. P. Freeman, Rachel Gilchrist, Mark J. Gharbi, Myriam Brannigan, Eimear T. Donaldson, Hugo Livermore, David M. Holmes, Alison H. |
author_sort | Moore, Luke S. P. |
collection | PubMed |
description | OBJECTIVES: We examined the 4 year trend in antimicrobial susceptibilities and prescribing across levels of care at two London teaching hospitals and their multisite renal unit, and for the surrounding community. METHODS: Laboratory and pharmacy information management systems were interrogated, with antimicrobial use and susceptibilities analysed between hospitals, within hospitals and over time. RESULTS: A total of 108 717 isolates from 71 687 patients were identified, with significant differences (at P < 0.05) in antimicrobial susceptibility between and within hospitals. Across the 4 years, rates of ESBL-/AmpC-producing Enterobacteriaceae ranged from 6.4% to 10.7% among community isolates, 17.8% to 26.9% at ward level and 25.2% to 52.5% in critical care. Significant variations were also demonstrated in glycopeptide-resistant enterococci (ward level 6.2%–17.4%; critical care 21.9%–56.3%), MRSA (ward level 18.5%–38.2%; critical care 12.5%–47.9%) and carbapenem-resistant Pseudomonas spp. (ward level 8.3%–16.9%; critical care 19.9%–53.7%). Few instances of persistently higher resistance were seen between the hospitals in equivalent cohorts, despite persistently higher antimicrobial use in Hospital 1 than Hospital 2. We found significant fluctuations in non-susceptibility year on year across the cohorts, but with few persistent trends. CONCLUSIONS: The marked heterogeneity of antimicrobial susceptibilities between hospitals, within hospitals and over time demands detailed, standardized surveillance and appropriate benchmarking to identify possible drivers and effective interventions. Homogeneous antimicrobial policies are unlikely to continue to be suitable as individual hospitals join hospital networks, and policies should be tailored to local resistance rates, at least at the hospital level, and possibly with finer resolution, particularly for critical care. |
format | Online Article Text |
id | pubmed-4228780 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-42287802014-11-13 Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London Moore, Luke S. P. Freeman, Rachel Gilchrist, Mark J. Gharbi, Myriam Brannigan, Eimear T. Donaldson, Hugo Livermore, David M. Holmes, Alison H. J Antimicrob Chemother Original Research OBJECTIVES: We examined the 4 year trend in antimicrobial susceptibilities and prescribing across levels of care at two London teaching hospitals and their multisite renal unit, and for the surrounding community. METHODS: Laboratory and pharmacy information management systems were interrogated, with antimicrobial use and susceptibilities analysed between hospitals, within hospitals and over time. RESULTS: A total of 108 717 isolates from 71 687 patients were identified, with significant differences (at P < 0.05) in antimicrobial susceptibility between and within hospitals. Across the 4 years, rates of ESBL-/AmpC-producing Enterobacteriaceae ranged from 6.4% to 10.7% among community isolates, 17.8% to 26.9% at ward level and 25.2% to 52.5% in critical care. Significant variations were also demonstrated in glycopeptide-resistant enterococci (ward level 6.2%–17.4%; critical care 21.9%–56.3%), MRSA (ward level 18.5%–38.2%; critical care 12.5%–47.9%) and carbapenem-resistant Pseudomonas spp. (ward level 8.3%–16.9%; critical care 19.9%–53.7%). Few instances of persistently higher resistance were seen between the hospitals in equivalent cohorts, despite persistently higher antimicrobial use in Hospital 1 than Hospital 2. We found significant fluctuations in non-susceptibility year on year across the cohorts, but with few persistent trends. CONCLUSIONS: The marked heterogeneity of antimicrobial susceptibilities between hospitals, within hospitals and over time demands detailed, standardized surveillance and appropriate benchmarking to identify possible drivers and effective interventions. Homogeneous antimicrobial policies are unlikely to continue to be suitable as individual hospitals join hospital networks, and policies should be tailored to local resistance rates, at least at the hospital level, and possibly with finer resolution, particularly for critical care. Oxford University Press 2014-12 2014-08-12 /pmc/articles/PMC4228780/ /pubmed/25118270 http://dx.doi.org/10.1093/jac/dku307 Text en © The Author 2014. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Original Research Moore, Luke S. P. Freeman, Rachel Gilchrist, Mark J. Gharbi, Myriam Brannigan, Eimear T. Donaldson, Hugo Livermore, David M. Holmes, Alison H. Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London |
title | Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London |
title_full | Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London |
title_fullStr | Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London |
title_full_unstemmed | Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London |
title_short | Homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in London |
title_sort | homogeneity of antimicrobial policy, yet heterogeneity of antimicrobial resistance: antimicrobial non-susceptibility among 108 717 clinical isolates from primary, secondary and tertiary care patients in london |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4228780/ https://www.ncbi.nlm.nih.gov/pubmed/25118270 http://dx.doi.org/10.1093/jac/dku307 |
work_keys_str_mv | AT moorelukesp homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon AT freemanrachel homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon AT gilchristmarkj homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon AT gharbimyriam homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon AT branniganeimeart homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon AT donaldsonhugo homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon AT livermoredavidm homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon AT holmesalisonh homogeneityofantimicrobialpolicyyetheterogeneityofantimicrobialresistanceantimicrobialnonsusceptibilityamong108717clinicalisolatesfromprimarysecondaryandtertiarycarepatientsinlondon |